Thomas Labs Fish Pen Forte – Penicillin 500mg 30 Tablets
Thomas Labs Fish Pen Forte – Penicillin 500mg 30 Tablets is a trusted and effective broad-spectrum antibiotic designed to combat bacterial infections in aquarium fish. Each tablet contains 500mg of penicillin, known for its action against gram-positive bacteria. Manufactured by Thomas Labs, this product ensures safe and effective treatment for your aquatic pets.
Key Benefits
- Broad-Spectrum Antibiotic: Targets gram-positive bacteria responsible for fin rot, gill disease, and other infections.
- Potent Formula: Contains 500mg of penicillin per tablet for reliable results.
- Aquarium Safe: Designed for aquarium fish, ensuring both safety and effectiveness.
- Trusted Brand: Backed by Thomas Labs, a leader in Fish Antibiotics.
- Convenient Packaging: Includes 30 tablets for single or multiple treatments.
Instructions
- Purpose: Fish Pen Forte treats bacterial infections in aquarium fish, including fin rot, columnaris, and septicemia.
- Dosage:
- Add 1 tablet (500mg) per 10 gallons of water.
- Repeat every 24 hours for 5-10 days, depending on the severity of the infection.
- Cautions:
- Not for human use.
- Remove activated carbon filters during treatment to maximize the antibiotic’s effectiveness.
- Monitor water quality and perform regular partial water changes as needed.
For detailed dosing instructions, visit the Fish Antibiotics Guide.
Ingredients
- Active Ingredient: Penicillin 500mg per tablet.
Related Products
- Thomas Labs Fish Pen – Penicillin 500mg 100 Tablets
- Thomas Labs Fish Mox Forte – Amoxicillin 500mg Capsules (100 Count)
- Thomas Labs Fish Flex Forte – Cephalexin 500mg Capsules (100 Count)
- Thomas Labs Fish Zole Forte – Metronidazole 500mg Tablets (60 Count)
- Thomas Labs Bird Biotic – Doxycycline 100mg Tablets (30 Count)
Tags
aquarium fish, fish infections, aquariums, penicillin, thomas labs, fish antibiotics, broad-spectrum antibiotics, fish medications, bacterial infection treatments, antibiotics for aquarium fish.
Reviews
There are no reviews yet.